Longeveron (NASDAQ:LGVN – Get Rating) will be announcing its earnings results before the market opens on Friday, May 12th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. Longeveron (NASDAQ:LGVN – Get Rating) last issued its quarterly earnings results on Friday, March 10th. The company reported ($0.21) EPS for the […]
EF Hutton Acquisition Co. I reiterated their buy rating on shares of Longeveron (NASDAQ:LGVN – Get Rating) in a research report report published on Monday, Benzinga reports. EF Hutton Acquisition Co. I currently has a $12.50 price target on the stock. Longeveron Price Performance Shares of LGVN stock opened at $2.68 on Monday. The company’s […]
– Expects to enroll first patient in Phase 2 clinical trial of Lomecel-B™ for Aging-Related Frailty in Japan in 1Q23 – – Extended cash runway into 2H24 – .
Longeveron Inc. (NASDAQ:LGVN – Get Rating) was the recipient of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 91,300 shares, a drop of 49.2% from the May 15th total of 179,800 shares. Currently, 2.3% of the company’s shares are short sold. Based on […]